Angelica E. Ehrenberg

Identification of weak points of hepatitis C virus NS3 protease inhibitors using surface plasmon resonance biosensor-based interaction kinetic analysis and genetic variants.

Benjamin Schmuck, Muhammad Ikram Anwar, U. Danielson, 2014, Journal of medicinal chemistry.

Vinylated linear P2 pyrimidinyloxyphenylglycine based inhibitors of the HCV NS3/4A protease and corresponding macrocycles.

E. Åkerblom, P. Artursson, A. Karlén, 2014, Bioorganic & medicinal chemistry.

Achiral pyrazinone-based inhibitors of the hepatitis C virus NS3 protease and drug-resistant variants with elongated substituents directed toward the S2 pocket.

E. Åkerblom, P. Artursson, A. Karlén, 2014, Journal of medicinal chemistry.

Accounting for strain variations and resistance mutations in the characterization of hepatitis C NS3 protease inhibitors

G. Stenberg, Benjamin Schmuck, Muhammad Ikram Anwar, 2014, Journal of enzyme inhibition and medicinal chemistry.

Discovery of achiral inhibitors of the hepatitis C virus NS3 protease based on 2(1H)-pyrazinones.

Aparna Vema, A. Karlén, M. Larhed, 2010, Bioorganic & medicinal chemistry.

P2-P1' macrocyclization of P2 phenylglycine based HCV NS3 protease inhibitors using ring-closing metathesis.

E. Åkerblom, G. Lindeberg, Aparna Vema, 2011, Bioorganic & medicinal chemistry.

Improved P2 phenylglycine-based hepatitis C virus NS3 protease inhibitors with alkenylic prime-side substituents.

G. Lindeberg, Aparna Vema, A. Karlén, 2010, Bioorganic & medicinal chemistry.

Pru p 7 sensitization is a predominant cause of severe, cypress pollen‐associated peach allergy

J. Lidholm, P. Demoly, I. Annesi-Maesano, 2019, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Characterization of a 7 kDa pollen allergen belonging to the gibberellin‐regulated protein family from three Cupressaceae species

J. Lidholm, J. Vitte, J. Östling, 2020, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Novel Procedures for Identification and Characterization of Viral Proteases Inhibitors

Angelica E. Ehrenberg, 2014 .

Structure–activity relationships of HCV NS3 protease inhibitors evaluated on the drug-resistant variants A156T and D168V

E. Åkerblom, Aparna Vema, A. Karlén, 2010, Antiviral therapy.